MEFLOQUINE Drug Patent Profile
✉ Email this page to a colleague
When do Mefloquine patents expire, and when can generic versions of Mefloquine launch?
Mefloquine is a drug marketed by Barr, Chartwell Rx, Hikma, Hikma Intl Pharms, and Us Army Walter Reed. and is included in five NDAs.
The generic ingredient in MEFLOQUINE is mefloquine hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mefloquine
A generic version of MEFLOQUINE was approved as mefloquine hydrochloride by CHARTWELL RX on February 20th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEFLOQUINE?
- What are the global sales for MEFLOQUINE?
- What is Average Wholesale Price for MEFLOQUINE?
Summary for MEFLOQUINE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for MEFLOQUINE |
| DailyMed Link: | MEFLOQUINE at DailyMed |


